Table 3.
Individual pre- to posttreatment (Tx) scores on training (TR) pictures (n = 40).
| PWA | Tx | Pre-Tx TR targets |
Days between Pre-Tx probes |
Daily probes during treatment period |
Post-Tx TR targets |
Days between Post-Tx probes |
Tx effect size a | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T1 | T2 | T3 | T1 to T2 | T2 to T3 | T4 | T5 | T6 | T7 | T8 | T9 | T10 | T11 | T12 | T13 | T14 | T15 | T16 | T13 to T14 | T14 to T15 | T15 to T16 | |||
| P1 | ILAT | 4 | 5 | 0 | 6 | 6 | 14 | 16 | 22 | 25 | 29 | 28 | 27 | 30 | 32 | 30 | 25 | 28 | 26 | 10 | 6 | 7 | 8.82 |
| P2 | ILAT | 0 | 0 | 1 | 6 | 12 | 0 | 2 | 3 | 4 | 5 | 3 | 11 | 2 | 8 | 4 | 6 | 9 | 14 | 10 | 12 | 9 | 16.17 |
| P3 | ILAT | 19 | 9 | 12 | 6 | 6 | n/a | 25 | 27 | 28 | 33 | 33 | 33 | 35 | 38 | 34 | 32 | 32 | 32 | 6 | 2 | 7 | 3.64 |
| P4 | ILAT | 14 | 18 | 16 | 6 | 6 | 21 | 30 | 28 | 32 | 30 | 31 | 34 | 33 | 33 | 30 | 27 | 28 | 30 | 11 | 7 | 6 | 6.17 |
| P5 | ILAT | 0 | 0 | 0 | 13 | 6 | 1 | 5 | 7 | 9 | 8 | 5 | 13 | 12 | 8 | 8 | 12 | 7 | 12 | 4 | 1 | 10 | 20.17 |
| P6 | ILAT | 0 | 0 | 0 | 13 | 13 | 2 | 6 | 5 | 2 | 4 | 1 | 1 | 5 | 5 | 3 | 4 | 2 | 5 | 3 | 1 | 4 | 3.17 |
| P7 | ILAT | 0 | 0 | 0 | 6 | 19 | n/a | 13 | 17 | 19 | 21 | 21 | 22 | 26 | 27 | 27 | 28 | 30 | 25 | 3 | 2 | 12 | 3.76 |
| P8 | ILAT | 0 | 3 | 0 | 13 | 13 | n/a | 12 | 14 | 19 | 24 | 23 | 20 | 21 | 24 | 24 | 25 | 21 | 22 | 3 | 1 | 1 | 12.51 |
| P9 | ILAT | 32 | 33 | 28 | 4 | 6 | 27 | 25 | 24 | 20 | 28 | 32 | 33 | 31 | 38 | 34 | 32 | 31 | 34 | 13 | 4 | 1 | 0.50 |
| P10 | ILAT | 3 | 7 | 3 | 34 | 34 | 13 | 20 | 19 | 24 | 21 | 26 | 29 | 32 | 31 | 34 | 30 | 35 | 31 | 11 | 1 | 5 | 11.98 |
| P11 | ILAT | 4 | 4 | 3 | 21 | 1 | 9 | 13 | 15 | 18 | 14 | 18 | 17 | 21 | 22 | 21 | 25 | 18 | 17 | 4 | 5 | 9 | 28.29 |
| P12 | ILAT | 3 | 5 | 8 | 13 | 1 | 17 | 20 | 21 | 28 | 23 | 25 | 32 | NA | 31 | 28 | 29 | 23 | 28 | 10 | 1 | 14 | 8.48 |
| P13 | PACE | 5 | 5 | 0 | 5 | 6 | 13 | 18 | 22 | 21 | 21 | 23 | 25 | 33 | 28 | NA | 29 | 27 | 27 | 3 | 6 | 6 | 8.43 |
| P14 | PACE | 0 | 0 | 0 | 13 | 6 | 4 | 7 | 12 | 10 | NA | 12 | 15 | 15 | 10 | 15 | 14 | 15 | 17 | 4 | 12 | 6 | 7.17 |
| P15 | PACE | 17 | 10 | 9 | 6 | 9 | 11 | 13 | 26 | 30 | 28 | 30 | 28 | NA | 32 | 33 | 33 | 35 | 30 | 7 | 16 | 16 | 4.74 |
| P16 | PACE | 0 | 4 | 2 | 6 | 9 | 9 | 17 | 15 | 28 | 29 | 27 | 28 | 31 | 29 | 32 | 31 | 29 | 29 | 7 | 16 | 16 | 13.83 |
| P17 | PACE | 0 | 0 | 0 | 13 | 22 | 0 | 4 | 4 | 10 | 10 | 7 | 5 | 6 | 9 | 11 | 9 | 7 | NA | 2 | 6 | NA | 3.50 |
| P18 | PACE | 0 | 0 | 0 | 13 | 13 | 0 | 0 | 3 | 3 | 5 | 5 | 5 | 3 | 2 | 6 | 2 | 6 | 3 | 4 | 1 | 4 | 1.94 |
| P19 | PACE | 14 | 13 | 16 | 25 | 20 | 27 | 35 | 36 | 36 | 37 | 37 | 36 | 36 | 34 | 34 | 36 | 36 | 33 | 4 | 5 | 1 | 13.53 |
| P20 | PACE | 2 | 2 | 2 | 20 | 41 | 1 | 1 | 10 | 6 | 7 | 9 | 10 | 9 | 8 | 13 | 8 | 6 | 7 | 4 | 14 | 6 | 10.50 |
| P21 | PACE | 7 | 6 | 3 | 6 | 1 | 12 | 23 | 22 | 28 | 29 | 21 | 25 | 23 | 24 | 32 | 22 | 28 | 25 | 13 | 1 | 1 | 9.45 |
| P22 | PACE | 7 | 4 | 5 | 6 | 6 | 4 | 4 | 5 | 10 | 7 | NA | 12 | 13 | 11 | 18 | 15 | 15 | 15 | 10 | 1 | 1 | 6.33 |
| P23 | PACE | 6 | 3 | 10 | 2 | 20 | 13 | 15 | 12 | 15 | 13 | 18 | 22 | 20 | 20 | 14 | 19 | 17 | 25 | 12 | 6 | 1 | 3.99 |
| P24 | PACE | 12 | 12 | 12 | 32 | 13 | 18 | NA | 13 | 17 | NA | 24 | 24 | 21 | 25 | NA | 22 | 23 | 25 | 5 | 4 | 1 | 3.28 |
Note. Days between pre- and posttreatment probes are shown in bold. PWA = participant with aphasia; T = time; ILAT = intensive language action therapy; n/a = data not available due to technical issues; PACE = promoting aphasic communicative effectiveness; NA = data not available due to participant missing session.
Tx effect size = Busk & Serlin's d score, where d = (Mean [post-Tx] − Mean [pre-Tx]) / SD [pre-Tx]; in cases where there was no variability in pre-Tx scores (italicized), the first available probe score (e.g., T4) was added for calculating M and SD pre-Tx.